Published Date: 01 Mar 2023
Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.
Read Full NewsDr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.
The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation and...
Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.
Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.
New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.
Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.
A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.
1.
Chemoimmunotherapy Boosts Head and Neck Cancer Response
2.
Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
3.
Novel radiotracer identifies biomarker for triple-negative breast cancer
4.
Discovery of breast cancer treatment resistance mechanism could lead to new hope for some
5.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
1.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
2.
Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies
3.
Survival Rate Dynamics in Hematologic and Solid Malignancies
4.
The Power of White Blood Cells: How They Help Keep Us Healthy
5.
Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation